NCT04001829 2026-04-21
Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
Clinical Trials
22 trialsNCT03488693 2026-04-14
TAILOR RT
Canadian Cancer Trials Group
Phase 3 Recruiting
NCT00802711 2026-04-13
3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast Cancer
Cancer Trials Ireland
Phase NA Terminated
NCT02630693 2026-04-13
Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer
Canadian Cancer Trials Group
Phase 2 Completed
NCT02705859 2026-04-13
Panther
Cancer Trials Ireland
Phase 1 Completed
NCT03843346 2026-04-13
The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer
Cancer Trials Ireland
Completed
NCT04650581 2026-04-13
FINER
Canadian Cancer Trials Group
Phase 3 Active not recruiting
NCT07297667 2026-04-13
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
Canadian Cancer Trials Group
Phase 1 Not yet recruiting
NCT03820830 2026-04-09
POLAR
ETOP IBCSG Partners Foundation
Phase 3 Active not recruiting
NCT04496739 2026-04-07
Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)
SWOG Cancer Research Network
Phase NA Active not recruiting
NCT03804255 2026-04-03
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
Eastern Cooperative Oncology Group
Withdrawn
NCT05108298 2026-04-03
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Eastern Cooperative Oncology Group
Phase NA Recruiting
NCT05710328 2026-04-03
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
NCT06112613 2026-04-03
Mobile Health for Adherence in Breast Cancer Patients
Eastern Cooperative Oncology Group
Phase NA Recruiting
NCT03723928 2026-04-02
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
SWOG Cancer Research Network
Phase NA Recruiting
NCT05076266 2026-04-02
COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation
Eastern Cooperative Oncology Group
Terminated
NCT05568472 2026-04-02
ASPEN
SWOG Cancer Research Network
Phase NA Active not recruiting
NCT02445391 2026-04-01
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
Eastern Cooperative Oncology Group
Phase 3 Active not recruiting
NCT00003140 2026-03-27
Letrozole After Tamoxifen in Treating Women With Breast Cancer
Canadian Cancer Trials Group
Phase 3 Completed
NCT00066443 2026-03-27
Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer
Canadian Cancer Trials Group
Phase 1/2 Completed
NCT03568422 2026-03-27
CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer
Canadian Cancer Trials Group
Phase 1/2 Active not recruiting
NCT05601440 2026-03-27
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
Canadian Cancer Trials Group
Phase 2 Recruiting